Clinical and Experimental Dermatology最新文献

筛选
英文 中文
Dermatopathology. 皮肤病理学。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag279
Alicia Dimech, David Pisani, Daniel Micallef, Lawrence Scerri
{"title":"Dermatopathology.","authors":"Alicia Dimech, David Pisani, Daniel Micallef, Lawrence Scerri","doi":"10.1093/ced/llag279","DOIUrl":"10.1093/ced/llag279","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1943-1945"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148338035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on 'Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma': can survival associations be inferred from selectively tested populations? 评论“黑素瘤中NRAS和KIT基因型的检测模式、患者和肿瘤特征和生存率”:是否可以从选择性检测人群中推断出生存关联?
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag246
Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou
{"title":"Comment on 'Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma': can survival associations be inferred from selectively tested populations?","authors":"Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou","doi":"10.1093/ced/llag246","DOIUrl":"10.1093/ced/llag246","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1933-1934"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148216483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multigenerational Huriez syndrome with marked intrafamilial heterogeneity and cutaneous squamous cell carcinoma burden. 多代Huriez综合征具有明显的家族内异质性和皮肤鳞状细胞癌负担。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag413
Brent J Doolan, Yiming Wang, Irene Lara-Corrales, Michelle Lee, Andrea Shugar, Elena Pope
{"title":"Multigenerational Huriez syndrome with marked intrafamilial heterogeneity and cutaneous squamous cell carcinoma burden.","authors":"Brent J Doolan, Yiming Wang, Irene Lara-Corrales, Michelle Lee, Andrea Shugar, Elena Pope","doi":"10.1093/ced/llag413","DOIUrl":"https://doi.org/10.1093/ced/llag413","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baricitinib vs. hydroxychloroquine for cutaneous lichen planus: an assessor-blind randomized controlled trial. 巴西替尼与羟氯喹治疗皮肤扁平苔藓:一项评估盲随机临床试验。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag210
Hossein Kargar, Mohammad Ali Esfandiari, Mehdi Ghahartars, Mohammad Mahdi Parvizi
{"title":"Baricitinib vs. hydroxychloroquine for cutaneous lichen planus: an assessor-blind randomized controlled trial.","authors":"Hossein Kargar, Mohammad Ali Esfandiari, Mehdi Ghahartars, Mohammad Mahdi Parvizi","doi":"10.1093/ced/llag210","DOIUrl":"10.1093/ced/llag210","url":null,"abstract":"<p><strong>Background: </strong>Lichen planus (LP) is a chronic autoimmune inflammatory disorder with limited effective long-term treatment options. Hydroxychloroquine has been widely used as systemic therapy, and although baricitinib, a Janus kinase 1/2 inhibitor, has shown promise in patients with refractory cases, comparative evidence is lacking.</p><p><strong>Objectives: </strong>This study aimed to compare the efficacy and safety of baricitinib vs. hydroxychloroquine in patients with cutaneous LP.</p><p><strong>Methods: </strong>In this randomized controlled trial, 32 patients with cutaneous LP were randomized to baricitinib 4 mg once daily or hydroxychloroquine 200 mg twice daily for 12 weeks. The primary outcome was the change in Lichen Planus Activity and Damage Index (LiPADI). Secondary outcomes included pruritus severity, patient satisfaction (each assessed using a 0-10 visual analogue scale) and Physician Global Assessment (PGA).</p><p><strong>Results: </strong>Both groups showed significant improvement in pruritus severity and LiPADI scores (P < 0.001). Mean LiPADI scores decreased from 14.20 (SD 3.44) to 1.07 (SD 0.99) with baricitinib and from 12.18 (SD 3.28) to 5.27 (SD 2.28) with hydroxychloroquine (P = 0.03), indicating a greater reduction in disease activity with baricitinib. The pruritus visual analogue scale improved from 8.33 (SD 1.67) to 0.21 (SD 0.80) in the baricitinib group and from 8.81 (SD 1.66) to 3.27 (SD 1.01) in the hydroxychloroquine group (P < 0.001). Patient satisfaction increased from 4.46 (SD 0.83) to 8.78 (SD 1.12) and from 4.63 (SD 0.50) to 6.90 (SD 0.94), respectively (P = 0.001). PGA improved in both groups, but the between-group difference was not statistically significant (P = 0.38). No major or life-threatening adverse events were observed in both groups.</p><p><strong>Conclusions: </strong>In this assessor-blinded randomized trial, both baricitinib and hydroxychloroquine improved cutaneous LP over 12 weeks. Baricitinib was associated with greater short-term improvement in disease activity and pruritus, along with higher patient satisfaction, without evidence of additional short-term safety concerns. The small sample size, short follow-up and nondouble-blind design warrant cautious interpretation. Large double-blind studies with longer follow-up are needed.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1865-1873"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147980505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current understanding and clinical management of congenital melanocytic naevi: a review. 先天性黑色素细胞痣的研究进展。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag219
Zeyu Liu, Mingyuan Xu, Jiashe Chen, Wei Tan, Xiaoxiang Xu, Yeqiang Liu
{"title":"Current understanding and clinical management of congenital melanocytic naevi: a review.","authors":"Zeyu Liu, Mingyuan Xu, Jiashe Chen, Wei Tan, Xiaoxiang Xu, Yeqiang Liu","doi":"10.1093/ced/llag219","DOIUrl":"10.1093/ced/llag219","url":null,"abstract":"<p><p>Congenital melanocytic naevi (CMN) are benign melanocytic proliferations originating from neural crest cells and presenting at birth or in early infancy with variable clinical manifestations and malignancy risks. The incidence of CMN varies by sex, with a higher prevalence in female patients but with potentially greater complications in male patients. Genetic studies have highlighted the pivotal role of mutations in BRAF and NRAS in influencing the size and malignancy risk of CMN. Diagnostic challenges necessitate a systematic approach, including histopathology, molecular profiling and risk-stratified therapeutic selection. This review synthesizes current knowledge on CMN epidemiology, molecular pathogenesis, diagnostic advancements and therapeutic strategies. Future directions emphasize the need for longitudinal studies to validate interventions, multidisciplinary collaboration and biomarker-driven personalized management.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1828-1839"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148052742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A waxy multinodular lesion on the upper lip in a young man. 年轻人上唇的蜡样多结节性病变。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag134
Noriyoshi Fujii, Yoshiyuki Ishii, Yuka Hatori, Mika Kurano, Toshifumi Nomura
{"title":"A waxy multinodular lesion on the upper lip in a young man.","authors":"Noriyoshi Fujii, Yoshiyuki Ishii, Yuka Hatori, Mika Kurano, Toshifumi Nomura","doi":"10.1093/ced/llag134","DOIUrl":"10.1093/ced/llag134","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1953-1955"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating lifestyle and nutritional care into psoriasis management: comment on 'Associations between lifestyle factors and life quality in people living with psoriasis: results of the Asking People with Psoriasis about Lifestyle and Eating (APPLE) cross-sectional study'. 对“牛皮癣患者生活方式因素与生活质量之间的关系:询问牛皮癣患者生活方式和饮食(APPLE)横断面研究的结果”的评论。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag227
Aparna Potluru, Yasmin Nikookam, Katherine Farquhar
{"title":"Integrating lifestyle and nutritional care into psoriasis management: comment on 'Associations between lifestyle factors and life quality in people living with psoriasis: results of the Asking People with Psoriasis about Lifestyle and Eating (APPLE) cross-sectional study'.","authors":"Aparna Potluru, Yasmin Nikookam, Katherine Farquhar","doi":"10.1093/ced/llag227","DOIUrl":"10.1093/ced/llag227","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1912-1913"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148052974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term multiorgan sequelae in a child with toxic epidermal necrolysis. 中毒性表皮坏死松解症患儿的长期多器官后遗症。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag220
Aoife Howard, Priyank Patel, Ravi Ramessur, Tess McPherson, Kapila Batta
{"title":"Long-term multiorgan sequelae in a child with toxic epidermal necrolysis.","authors":"Aoife Howard, Priyank Patel, Ravi Ramessur, Tess McPherson, Kapila Batta","doi":"10.1093/ced/llag220","DOIUrl":"10.1093/ced/llag220","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1909-1911"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148052997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public perceptions of suncream toxicity: a content analysis on Reddit. 公众对防晒霜毒性的看法:Reddit上的内容分析。
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag241
Sanaz Lordfard, Edgar Akuffo-Addo, Nandi Edwards, Katya Peri, Jeannie Boisvert, Sameh Hanna
{"title":"Public perceptions of suncream toxicity: a content analysis on Reddit.","authors":"Sanaz Lordfard, Edgar Akuffo-Addo, Nandi Edwards, Katya Peri, Jeannie Boisvert, Sameh Hanna","doi":"10.1093/ced/llag241","DOIUrl":"10.1093/ced/llag241","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1928-1930"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148204189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis': does persistence among responders equal durable disease control? 评论“Lebrikizumab为特应性皮炎患者提供稳定的皮肤反应,长达2年无波动或波动最小”:反应者的持久性是否等同于持久的疾病控制?
IF 2.8 4区 医学
Clinical and Experimental Dermatology Pub Date : 2026-09-25 DOI: 10.1093/ced/llag244
Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou
{"title":"Comment on 'Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis': does persistence among responders equal durable disease control?","authors":"Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou","doi":"10.1093/ced/llag244","DOIUrl":"10.1093/ced/llag244","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1926-1927"},"PeriodicalIF":2.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148210304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书